1921
Volume 101, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Mucocutaneous leishmaniasis (MCL) is a rare infection caused by several species within the genus . We present a patient with multifocal MCL masquerading as idiopathic midline granulomatous disease, featuring the unusual complication of ocular leishmaniasis, as a result of prolonged immunosuppressive therapy. We review clinical features, diagnosis, and treatment of this syndrome.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0259
2019-09-23
2020-09-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/101/5/tpmd190259.html?itemId=/content/journals/10.4269/ajtmh.19-0259&mimeType=html&fmt=ahah

References

  1. Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, Carvalho E, Ephros M, Jeronimo S, Magill A, 2016. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis 63: 15391557.
    [Google Scholar]
  2. Herwaldt BL, 1999. Leishmaniasis. Lancet 354: 11911199.
    [Google Scholar]
  3. Reed SG, Sott P, 1993. T cell and cytokine responses in leishmnaniasis. Curr Opin Immunol 5: 524531.
    [Google Scholar]
  4. Motta AC, Arruda D, Souza CS, Foss NT, 2003. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. Int J Dermatol 42: 703706.
    [Google Scholar]
  5. Tuon FF, Sabbaga Amato V, Floeter-Winter LM, de Andrade Zampieri R, Amato Neto V, Siqueira França FO, Shikanai-Yasuda MA, 2007. Utaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids–first report. Int J Dermatol 46: 628.
    [Google Scholar]
  6. Bogdan C, 2012. Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats. Ann Rheum Dis 71 (Suppl 2): i60.
    [Google Scholar]
  7. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M, 2008. Leishmaniasis among organ transplant recipients. Lancet Infect Dis 8: 191199.
    [Google Scholar]
  8. Couppie P, Clyti E, Sobesky M, Bissuel F, Del Giudice P, Sainte-Marie D, Dedet JP, Carme B, Pradinaud R, 2004. Comparative study of cutaneous leishmanaisis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Giana. Br J Dermatol 151: 11651171.
    [Google Scholar]
  9. Gurel M, Ulukanligil M, Ozbilge H, 2002. Cutaneous leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997–2000). Int J Dermatol 41: 3237.
    [Google Scholar]
  10. Durdu M, Gokce S, Bagirova M, Yalaz M, Allahverdiyev AM, Uzun S, 2007. Periocular involvement in cutaneous leishmaniasis. J Eur Acad Dermatol Venereol 21: 214218.
    [Google Scholar]
  11. Veraldi S, Bottini S, Curro N, Gianotti R, 2010. Leishmaniasis of the eyelid mimicking an infundibular cyst and review of the literature on ocular leishmaniasis. Int J Infect Dis 14 (Suppl 3): e230232.
    [Google Scholar]
  12. Nikandish M, Goyonio VM, Taheri AR, Kiafar B, 2016. Ocular leishmaniasis treated by intralesional amphotericin B. Middle East Afr J Ophthalmol 23: 153155.
    [Google Scholar]
  13. Chu F, Rodrigues M, Cogan D, Neva FA, 1983. Leishmaniasis affecting the eyelids. Arch Ophthalmol 101: 8491.
    [Google Scholar]
  14. De Almeida ME, Steruer FJ, Koru O, Herwaldt BL, Pieniazek NJ, da Silva AJ, 2011. Identification of Leishmania spp. by molecular amplification and DNA sequencing analysis of a fragment of rRNA internal transcribed spacer 2. J Clin Microbiol 49: 31433149.
    [Google Scholar]
  15. Gonzalez U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA, 2009. Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev 2009: CD004834.
    [Google Scholar]
  16. Amato VS, Tuon FF, Siqueira AM, Nicodemo AC, Neto VA, 2007. Treatment of mucosal leishmaniasis in Latin America: systematic review. Am J Trop Med Hyg 77: 266274.
    [Google Scholar]
  17. Murray HW, 2012. Leishmaniasis in the United States: treatment in 2012. Am J Trop Med Hyg 86: 434440.
    [Google Scholar]
  18. Soto J et al., 2007. Treatment of Bolivian mucosal leishmaniasis with miltefosine. CID 44: 350356.
    [Google Scholar]
  19. Soto J, Rea J, Valderrama M, Toledo J, Valda L, Ardiles J, Berman J, 2009. Short report: efficacy of extended (six weeks) treatment with miltefosine for mucosal leishmaniasis in Bolivia. Am J Trop Med Hyg 81: 387389.
    [Google Scholar]
  20. Amato VS, Tuon FF, Campos A, Bacha HA, Nicodemo AC, Amato Neto V, Shikanai-Yasuda MA, 2007. Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B. CID 44: 311312.
    [Google Scholar]
  21. Rocio C, Amato VS, Camargo RA, Nicodemo AC, 2014. Liposomal formulation of amphotericin B for treatment of mucosal leishmaniasis in HIV-negative patients. Trans R Soc Trop Med Hyg 108: 176178.
    [Google Scholar]
  22. Doroodgar M, Doroodgar M, Doroodgar A, 2017. Eyelid cutaneous leishmaniasis: a case report. Iran J Public Health 46: 261264.
    [Google Scholar]
  23. Doroodgar M, Doroodgar M, Doroodgar A, 2017. Unusual presentation of cutaneous leishmaniasis: ocular leishmaniasis. Case Rep Infect Dis 2017: 14.
    [Google Scholar]
  24. Mohammadpour I, Motazedian MH, Handjani F, Hatam GR, 2016. Cutaneous leishmaniasis of the eyelids: a case series with molecular identification and literature review. Korean J Parasitol 54: 787792.
    [Google Scholar]
  25. Sadeghian G, Nilfroushzadeh MA, Moradi SH, Hanjani SH, 2005. Ocular leishmaniasis: a case report. Dermatol Online J 11: 19.
    [Google Scholar]
  26. Abrishami M, Soheilian M, Farahi A, Dowlati Y, 2002. Successful treatment of ocular leishmaniasis. Eur J Dermatol 12: 8889.
    [Google Scholar]
  27. Razeghinejad MR, Monabati A, Kadivar MR, Alborzi A, 2017. Conjunctival leishmaniasis in a case of disseminated cutaneous leishmaniasis. Trop Doct 47: 5355.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0259
Loading
/content/journals/10.4269/ajtmh.19-0259
Loading

Data & Media loading...

  • Received : 04 Apr 2019
  • Accepted : 14 Jul 2019
  • Published online : 23 Sep 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error